ArticleOncotarget2015

Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.

Qin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.